Na · Journal of neurology 2025 · prospective cohort study · n=93578

Physical activity and Alzheimer's disease risk across genetic susceptibility: a prospective UK Biobank study using accelerometer data.

Cited 1 times in the scientific literature.

Level 3 - non-randomized controlled study

Prospective observational cohort study

PubMed 41329349 · doi:10.1007/s00415-025-13524-z · record verified 2026-08-30

What was done

Analyzed 93,578 UK Biobank participants aged 40–70 years who had wrist-worn accelerometer data and genome-wide genotyping. Physical activity was quantified continuously in milligravity (mg) and dichotomized using an optimal threshold from maximally selected rank statistics. Genetic susceptibility was evaluated via polygenic risk scores (PRS) and APOE ε4 carrier status. Cox proportional hazards models estimated hazard ratios for incident Alzheimer's disease (AD) across genetic risk groups and evaluated interactions over a median 15.5-year follow-up.

What was found

Among 401 incident AD cases, high physical activity reduced AD risk by 48% (HR 0.517, 95% CI 0.300–0.891), while high PRS increased risk (HR 2.423, 95% CI 1.757–3.343). The protective association of physical activity was consistent across all PRS and APOE ε4 strata, with no significant additive (RERI = -0.566, 95% CI -4.574 to 3.441) or multiplicative interaction. Dose-response analysis identified an optimal benefit threshold at 21.7 mg, corresponding to light-intensity physical activity.

Why it matters

This study demonstrates that the protective association between objectively tracked physical activity and Alzheimer's disease extends across all genetic risk tiers, including APOE ε4 carriers. It suggests that even light-intensity physical activity may serve as an effective lifestyle intervention for dementia risk reduction.

Limits

The observational design cannot establish causality or completely eliminate the possibility of reverse causation (preclinical cognitive decline reducing physical activity). Physical activity was measured during a single accelerometer assessment rather than over a lifetime. The UK Biobank is subject to healthy volunteer selection bias and consists largely of individuals of European ancestry.

Cited by